Pharmacology Comprehensive Exam 2
Questions, Answers & Rationales for
2026[Chamberlain]
1. A patient is prescribed a medication that has a half-life of 24 hours. How long will it take for the drug
to reach a steady state?
A. 24 hours
B. 48 hours
C. 72 hours
D. 96 hours
Answer: D. 96 hours
Rationale:
A. Incorrect. Steady state is reached in approximately 4-5 half-lives, not one.
B. Incorrect. 48 hours represents only two half-lives, which is not enough to reach steady state.
C. Incorrect. 72 hours represents three half-lives; steady state is achieved at 4-5 half-lives.
D. Correct. It takes roughly 4-5 half-lives for a drug to reach steady state. With a 24-hour half-life, 4 half-
lives equal 96 hours (4 days). At this point, drug accumulation and elimination are equal.
2. Which of the following statements best describes the mechanism of action of a prodrug?
A. It is active immediately upon administration.
B. It requires biotransformation to become an active drug.
C. It binds directly to the receptor site without modification.
D. It is excreted unchanged in the urine.
,Answer: B. It requires biotransformation to become an active drug.
Rationale:
A. Incorrect. A prodrug is inactive or has low activity in its administered form.
B. Correct. A prodrug is a pharmacologically inactive compound that is metabolized into an active drug
within the body.
C. Incorrect. This describes an active drug, not a prodrug.
D. Incorrect. Excretion of an unchanged drug is a characteristic of some drugs, but not a defining feature
of a prodrug.
3. A drug that acts as an agonist at a receptor will have what effect?
A. It will block the receptor and prevent a response.
B. It will bind to the receptor and produce a response.
C. It will only bind to the receptor if there is a high concentration of the drug.
D. It will be excreted rapidly by the kidneys.
Answer: B. It will bind to the receptor and produce a response.
Rationale:
A. Incorrect. This describes an antagonist, which blocks the receptor.
B. Correct. An agonist binds to a receptor and activates it, producing a biological response. It has both
affinity and intrinsic activity.
C. Incorrect. Binding affinity is a property of the drug, not solely dependent on concentration.
D. Incorrect. This refers to excretion, which is not the defining action of an agonist.
4. The movement of a drug from the site of administration into the bloodstream is known as:
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Answer: C. Absorption
,Rationale:
A. Incorrect. Distribution is the movement of the drug from the bloodstream to the tissues.
B. Incorrect. Metabolism is the biotransformation of the drug into a metabolite.
C. Correct. Absorption is the process by which a drug moves from its site of administration into the
systemic circulation.
D. Incorrect. Excretion is the elimination of the drug from the body.
5. Which of the following routes of administration has the highest bioavailability?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
Answer: D. Intravenous
Rationale:
A. Incorrect. Oral drugs undergo first-pass metabolism and have variable absorption, leading to less than
100% bioavailability.
B. Incorrect. Subcutaneous absorption is slower and more variable than IV.
C. Incorrect. Intramuscular absorption is faster than subcutaneous but still less than IV.
D. Correct. Intravenous administration delivers the drug directly into the bloodstream, bypassing
absorption barriers and resulting in 100% bioavailability.
6. A patient with renal failure is most likely to experience which pharmacokinetic alteration?
A. Increased drug metabolism
B. Decreased drug excretion
C. Increased drug absorption
D. Increased protein binding
Answer: B. Decreased drug excretion
Rationale:
, A. Incorrect. The liver is the primary site of metabolism, not the kidneys.
B. Correct. The kidneys are the primary organs for drug excretion. Renal failure leads to decreased
glomerular filtration and tubular secretion, resulting in drug accumulation.
C. Incorrect. Absorption is not directly affected by renal failure, though it can be altered by other factors
like GI motility.
D. Incorrect. Protein binding is affected by liver disease or hypoalbuminemia, not primarily by renal
failure, though uremia can alter binding.
7. A drug that is highly bound to plasma proteins will have which characteristic?
A. A large volume of distribution
B. A high rate of renal excretion
C. A low volume of distribution
D. A high rate of hepatic metabolism
Answer: C. A low volume of distribution
Rationale:
A. Incorrect. A large volume of distribution is associated with high tissue binding, not plasma protein
binding.
B. Incorrect. High protein binding limits the amount of free drug available for glomerular filtration, thus
decreasing renal excretion.
C. Correct. A highly protein-bound drug is confined to the vascular space, resulting in a low volume of
distribution.
D. Incorrect. Metabolism is a function of hepatic enzymes, not protein binding.
8. A patient is given a drug that is a weak acid. Which of the following conditions would promote its
excretion in the urine?
A. Acidification of the urine
B. Alkalinization of the urine
C. Decreased renal blood flow
D. Increased protein binding
Questions, Answers & Rationales for
2026[Chamberlain]
1. A patient is prescribed a medication that has a half-life of 24 hours. How long will it take for the drug
to reach a steady state?
A. 24 hours
B. 48 hours
C. 72 hours
D. 96 hours
Answer: D. 96 hours
Rationale:
A. Incorrect. Steady state is reached in approximately 4-5 half-lives, not one.
B. Incorrect. 48 hours represents only two half-lives, which is not enough to reach steady state.
C. Incorrect. 72 hours represents three half-lives; steady state is achieved at 4-5 half-lives.
D. Correct. It takes roughly 4-5 half-lives for a drug to reach steady state. With a 24-hour half-life, 4 half-
lives equal 96 hours (4 days). At this point, drug accumulation and elimination are equal.
2. Which of the following statements best describes the mechanism of action of a prodrug?
A. It is active immediately upon administration.
B. It requires biotransformation to become an active drug.
C. It binds directly to the receptor site without modification.
D. It is excreted unchanged in the urine.
,Answer: B. It requires biotransformation to become an active drug.
Rationale:
A. Incorrect. A prodrug is inactive or has low activity in its administered form.
B. Correct. A prodrug is a pharmacologically inactive compound that is metabolized into an active drug
within the body.
C. Incorrect. This describes an active drug, not a prodrug.
D. Incorrect. Excretion of an unchanged drug is a characteristic of some drugs, but not a defining feature
of a prodrug.
3. A drug that acts as an agonist at a receptor will have what effect?
A. It will block the receptor and prevent a response.
B. It will bind to the receptor and produce a response.
C. It will only bind to the receptor if there is a high concentration of the drug.
D. It will be excreted rapidly by the kidneys.
Answer: B. It will bind to the receptor and produce a response.
Rationale:
A. Incorrect. This describes an antagonist, which blocks the receptor.
B. Correct. An agonist binds to a receptor and activates it, producing a biological response. It has both
affinity and intrinsic activity.
C. Incorrect. Binding affinity is a property of the drug, not solely dependent on concentration.
D. Incorrect. This refers to excretion, which is not the defining action of an agonist.
4. The movement of a drug from the site of administration into the bloodstream is known as:
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Answer: C. Absorption
,Rationale:
A. Incorrect. Distribution is the movement of the drug from the bloodstream to the tissues.
B. Incorrect. Metabolism is the biotransformation of the drug into a metabolite.
C. Correct. Absorption is the process by which a drug moves from its site of administration into the
systemic circulation.
D. Incorrect. Excretion is the elimination of the drug from the body.
5. Which of the following routes of administration has the highest bioavailability?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
Answer: D. Intravenous
Rationale:
A. Incorrect. Oral drugs undergo first-pass metabolism and have variable absorption, leading to less than
100% bioavailability.
B. Incorrect. Subcutaneous absorption is slower and more variable than IV.
C. Incorrect. Intramuscular absorption is faster than subcutaneous but still less than IV.
D. Correct. Intravenous administration delivers the drug directly into the bloodstream, bypassing
absorption barriers and resulting in 100% bioavailability.
6. A patient with renal failure is most likely to experience which pharmacokinetic alteration?
A. Increased drug metabolism
B. Decreased drug excretion
C. Increased drug absorption
D. Increased protein binding
Answer: B. Decreased drug excretion
Rationale:
, A. Incorrect. The liver is the primary site of metabolism, not the kidneys.
B. Correct. The kidneys are the primary organs for drug excretion. Renal failure leads to decreased
glomerular filtration and tubular secretion, resulting in drug accumulation.
C. Incorrect. Absorption is not directly affected by renal failure, though it can be altered by other factors
like GI motility.
D. Incorrect. Protein binding is affected by liver disease or hypoalbuminemia, not primarily by renal
failure, though uremia can alter binding.
7. A drug that is highly bound to plasma proteins will have which characteristic?
A. A large volume of distribution
B. A high rate of renal excretion
C. A low volume of distribution
D. A high rate of hepatic metabolism
Answer: C. A low volume of distribution
Rationale:
A. Incorrect. A large volume of distribution is associated with high tissue binding, not plasma protein
binding.
B. Incorrect. High protein binding limits the amount of free drug available for glomerular filtration, thus
decreasing renal excretion.
C. Correct. A highly protein-bound drug is confined to the vascular space, resulting in a low volume of
distribution.
D. Incorrect. Metabolism is a function of hepatic enzymes, not protein binding.
8. A patient is given a drug that is a weak acid. Which of the following conditions would promote its
excretion in the urine?
A. Acidification of the urine
B. Alkalinization of the urine
C. Decreased renal blood flow
D. Increased protein binding
